Volume 96, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Dengue virus (DENV) is a serious threat to public health. Having reliable estimates of the burden of dengue is important to inform policy and research, but surveillance systems are not designed to capture all symptomatic DENV infections. We derived the rate of reporting of dengue by comparing active surveillance of symptomatic DENV infections in a prospective community-based seroepidemiological cohort study ( = 1008) of acute febrile illness in Punta Princesa, Cebu City, Philippines, with passive surveillance data from the Cebu City Health Department. Febrile episodes detected in a weekly follow-up of participants were tested for serotype-specific DENV by hemi-nested reverse transcription-polymerase chain reaction (nested RT-PCR) and acute/convalescent blood samples tested by dengue IgM/IgG enzyme immunoassay. We estimated the burden of dengue in the Philippines in disability-adjusted life years (DALYs), and conducted a probabilistic sensitivity analysis using Monte-Carlo simulations to address uncertainty. The results showed a 21% cumulative reporting rate of symptomatic DENV infections, equivalent to an expansion factor of 4.7 (95% certainty level [CL]: 2.2–15.1). Based on surveillance data in the Philippines for 2010–2014, we estimated 794,255 annual dengue episodes (95% CL: 463,000–2,076,000) and a disease burden of 535 (95% CL: 380–994) DALYs per million population using age weights and time discounting and 997 (95% CL: 681–1,871) DALYs per million population without age and time adjustments. Dengue imposes a substantial burden in the Philippines; almost 10 times higher than estimated for rabies, about twice the burden of intestinal fluke infections, and about 10% of the burden of tuberculosis. Our estimates should inform policy makers and raise awareness among the public.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

Loading full text...

Full text loading...



  1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GRW, Simmons CP, Scott TW, Farrar JJ, Hay SI, , 2013. The global distribution and burden of dengue. Nature 496: 504507.[Crossref]
  2. Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, Hay SI, Bedi N, Bensenor IM, Castañeda-Orjuela CA, Chuang T-W, Gibney KB, Memish ZA, Rafay A, Ukwaja KN, Yonemoto N, Murray CJL, , 2016. The global burden of dengue: a systematic analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 16: 712723.[Crossref]
  3. Shepard DS, Halasa YA, Undurraga EA, Gubler DJ, Ooi EE, Vasudevan SG, Farrar J, , 2014. Economic and disease burden of dengue. , eds. Dengue and Dengue Hemorrhagic Fever. Wallingford, UK: CAB International, 5077.
  4. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH, , 2011. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 84: 200207.[Crossref]
  5. Shepard DS, Undurraga EA, Halasa YA, , 2013. Economic and disease burden of dengue in Southeast Asia. PLoS Negl Trop Dis 7: e2055.[Crossref]
  6. Shepard DS, Undurraga EA, Halasa YA, Stanaway JD, , 2016. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis 16: 935941.[Crossref]
  7. World Health Organization, 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New edition. Available at: http://apps.who.int/iris/bitstream/10665/44188/1/9789241547871_eng.pdf. Accessed September 8, 2016.
  8. Simmons CP, Farrar JJ, Nguyen VVC, Wills B, , 2012. Current concepts: dengue. N Engl J Med 366: 14231432.[Crossref]
  9. Bravo L, Roque VG, Brett J, Dizon R, L'Azou M, , 2014. Epidemiology of dengue disease in the Philippines (2000–2011): a systematic literature review. PLoS Negl Trop Dis 8: e3027.[Crossref]
  10. Edillo FE, Halasa YA, Largo FM, Erasmo JNV, Amoin NB, Alera MTP, Yoon I-K, Alcantara AC, Shepard DS, , 2015. Economic cost and burden of dengue in the Philippines. Am J Trop Med Hyg 92: 360366.[Crossref]
  11. Edillo F, Madarieta S, , 2012. Trends of dengue infections (1997–2008) in Cebu Province, Philippines. Dengue Bull 36: 3749.
  12. Undurraga EA, Halasa YA, Shepard DS, , 2013. Use of expansion factors to estimate the burden of dengue in Southeast Asia: a systematic analysis. PLoS Negl Trop Dis 7: e2056.[Crossref]
  13. World Health Organization, Western Pacific Region, 2013. Emerging Disease Surveillance and Response: Dengue Situation Updates. WPRO 2014. Available at: http://www.wpro.who.int/emerging_diseases/DengueSituationUpdates/en/. Accessed January 7, 2014.
  14. Dominguez NN, , 1997. Current DF/DHF prevention and control programme in the Philippines. Dengue Bull 21: 4147.
  15. Department of Health, Republic of the Philippines, 2012. Disease Surveillance, Dengue Morbidity. Available at: http://dev1.doh.gov.ph/disease-surveillance. Accessed January 7, 2014.
  16. Capeding MR, , 2012. Dengue Surveillance and Diagnostics in the Philippines. First Asian Dengue Vaccination Advocacy (ADVA) Group Regional Workshop, Bangkok, Thailand, September 21–23, 2012.
  17. National Epidemiology Center, 2008. Manual of Procedures for the Philippine Integrated Disease Surveillance and Response. Manila, Philippines: Department of Health Philippines.
  18. Edillo FE, Erasmo JN, Halasa YA, Amoin NB, Largo FM, Shepard DS, , 2013. Dengue surveillance system in action in the Philippines. Am J Trop Med Hyg 89: 178.[Crossref]
  19. Duarte HHP, Franca EB, , 2006. Data quality of dengue epidemiological surveillance in Belo Horizonte, southeastern Brazil. Rev Saude Publica 40: 134142.[Crossref]
  20. Tien NTK, Luxemburger C, Toan NT, Pollissard-Gadroy L, Houng VTQ, Be PV, Rang NN, Wartel TA, Lang J, , 2010. A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam. Trans R Soc Trop Med Hyg 104: 592600.[Crossref]
  21. Wichmann O, Yoon IK, Vong S, Limkittikul K, Gibbons RV, Mammen MP, Ly S, Buchy P, Sirivichayakul C, Buathong R, Huy R, Letson GW, Sabchareon A, , 2011. Dengue in Thailand and Cambodia: an assessment of the degree of underrecognized disease burden based on reported cases. PLoS Negl Trop Dis 5: e996.[Crossref]
  22. Shepard DS, Undurraga EA, Lees RS, Halasa YA, Lum L, Ng CW, , 2012. Use of multiple data sources to estimate the economic cost of dengue illness in Malaysia. Am J Trop Med Hyg 87: 796805.[Crossref]
  23. Montoya M, Gresh L, Mercado JC, Williams KL, Vargas MJ, Gutierrez G, Kuan G, Gordon A, Balmaseda A, Harris E, , 2013. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis 7: e2357.[Crossref]
  24. Torres JR, Torres CG, , 2002. Dengue in Latin America. A unique situation. Dengue Bull 26: 6269.
  25. Halstead SB, , 2006. Dengue in the Americas and southeast Asia: do they differ? Rev Panam Salud Publica 20: 407415.[Crossref]
  26. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, , 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 29.[Crossref]
  27. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon IK, Jarman RG, Green S, Rothman AL, Cummings DAT, , 2010. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4: e617.[Crossref]
  28. Gibbons RV, Kalanarooj S, Jarman RG, Nisalak A, Vaughn DW, Endy TP, Mammen MP, Srikiatkhachorn A, , 2007. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg 77: 910913.
  29. Olkowski S, Forshey BM, Morrison AC, Rocha C, Vilcarromero S, Halsey ES, Kochel TJ, Scott TW, Stoddard ST, , 2013. Reduced risk of disease during postsecondary dengue virus infections. J Infect Dis 208: 10261033.[Crossref]
  30. Guzman MG, Alvarez M, Halstead SB, , 2013. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 158: 14451459.[Crossref]
  31. Sierra BDL, Kouri G, Guzman MG, , 2007. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152: 533542.[Crossref]
  32. Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, Sun W, Kanesa-Thasan N, Hayes CG, Watts DM, , 2001. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg 65: 180183.
  33. Sharp TM, Moreira R, Soares MJ, da Costa LM, Mann J, DeLorey M, Hunsperger E, Muñoz-Jordán JL, Colón C, Margolis HS, , 2015. Underrecognition of dengue during 2013 epidemic in Luanda, Angola. Emerg Infect Dis 21: 1311.[Crossref]
  34. Senn N, Luang-Suarkia D, Manong D, Max Siba P, Hannan McBride WJ, , 2011. Contribution of dengue fever to the burden of acute febrile illnesses in Papua New Guinea: an age-specific prospective study. Am J Trop Med Hyg 85: 132.[Crossref]
  35. Ellis EM, Neatherlin JC, Delorey M, Ochieng M, Mohamed AH, Mogeni DO, Hunsperger E, Patta S, Gikunju S, Waiboic L, Fields B, Ofula V, Konongoi SL, Torres-Velasquez B, Marano N, Sang R, Margolis HS, Montgomery JM, Tomashek KM, , 2015. A household serosurvey to estimate the magnitude of a dengue outbreak in Mombasa, Kenya, 2013. PLoS Negl Trop Dis 9: e0003733.[Crossref]
  36. Stoler J, Delimini RK, Bonney JK, Oduro AR, Owusu-Agyei S, Fobil JN, Awandare GA, , 2015. Evidence of recent dengue exposure among malaria parasite-positive children in three urban centers in Ghana. Am J Trop Med Hyg 92: 497500.[Crossref]
  37. Guzman MG, Jaenisch T, Gaczkowski R, Vo TTH, Sekaran SD, Kroeger A, Vazquez S, Ruiz D, Martinez E, Mercado JC, Balmaseda A, Harris E, Dimano E, Leano PSA, Yoksan S, Villegas E, Benduzu H, Villalobos I, Farrar J, Simmons CP, , 2010. Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis 4: e811.[Crossref]
  38. Guzmán MG, Kouri G, , 2004. Dengue diagnosis, advances and challenges. Int J Infect Dis 8: 6980.[Crossref]
  39. Shepard DS, Undurraga EA, Betancourt-Cravioto M, Guzmán MG, Halstead SB, Harris E, Mudin RN, Murray KO, Tapia-Conyer R, Gubler DJ, , 2014. Approaches to refining estimates of global burden and economics of dengue. PLoS Negl Trop Dis 8: e3306.[Crossref]
  40. Toan NT, Rossi S, Prisco G, Nante N, Viviani S, , 2015. Dengue epidemiology in selected endemic countries: factors influencing expansion factors as estimates of underreporting. Trop Med Int Health 20: 840863.[Crossref]
  41. Sarti E, L'Azou M, Mercado M, Kuri P, Siqueira JB, Jr Solis E, Noriega F, Ochiai RL, , 2016. A comparative study on active and passive epidemiological surveillance for dengue in five countries of Latin America. Int J Infect Dis 44: 4449.[Crossref]
  42. Tomashek KM, Gregory CJ, Rivera Sánchez A, Bartek MA, Garcia Rivera EJ, Hunsperger E, Muñoz-Jordán JL, Sun W, , 2012. Dengue deaths in Puerto Rico: lessons learned from the 2007 epidemic. PLoS Negl Trop Dis 6: e1614.[Crossref]
  43. Pamplona LG, de Melo Braga DN, da Silva LMA, Aguiar MG, Castiglioni M, Silva-Junior JU, de Carvalho Araújo FM, da Costa Pereira RA, Malta DL, de Lima Pompeu MM, , 2016. Postmortem diagnosis of dengue as an epidemiological surveillance tool. Am J Trop Med Hyg 94: 187192.[Crossref]
  44. Vong S, Goyet S, Ly S, Ngan C, Huy R, Duong V, Wichmann O, Letson GW, Margolis HS, Buchy P, , 2012. Under-recognition and reporting of dengue in Cambodia: a capture-recapture analysis of the National Dengue Surveillance System. Epidemiol Infect 140: 491499.[Crossref]
  45. Olkowski S, Stoddard ST, Halsey ES, Morrison AC, Barker CM, Scott TW, , 2016. Sentinel versus Passive Surveillance for Measuring Changes in Dengue Incidence: Evidence from Three Concurrent Surveillance Systems in Iquitos, Peru. Available at: http://biorxiv.org/content/biorxiv/early/2016/02/18/040220.full.pdf. Accessed March 5, 2016.
  46. DeRoeck D, Deen J, Clemens JD, , 2003. Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries. Vaccine 22: 121129.[Crossref]
  47. Beatty ME, Stone A, Fitzsimons DW, Hanna JN, Lam SK, Vong S, Guzman MG, Mendez-Galvan JF, Halstead SB, Letson GW, Kuritsky J, Mahoney R, Margolis HS, for The Asia-Pacific and Americas Dengue Prevention Boards Surveillance Working Group, , 2010. Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis 4: e890.[Crossref]
  48. Racloz V, Ramsey R, Tong SL, Hu WB, , 2012. Surveillance of dengue fever virus: a review of epidemiological models and early warning systems. PLoS Negl Trop Dis 6: e1648.[Crossref]
  49. Badurdeen S, Valladares DB, Farrar J, Gozzer E, Kroeger A, Kuswara N, Ranzinger SR, Tinh HT, Leite P, Mahendradhata Y, Skewes R, Verrall A, WHO/TDR Working Group; , 2013. Sharing experiences: towards an evidence based model of dengue surveillance and outbreak response in Latin America and Asia. BMC Public Health 13: 607.[Crossref]
  50. Ooi EE, Gubler D, Nam V, , 2007. Dengue Research Needs Related to Surveillance and Emergency Response. Report to the Scientific Working Group Meeting on Dengue, Geneva, October 1–5, 2006. Geneva, Switzerland: World Health Organization (WHO), 124133.
  51. Murray CJL, , 1994. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 72: 429445.
  52. Meltzer MI, Rigau-Perez JG, Clark GG, Reiter P, Gubler DJ, , 1998. Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984–1994. Am J Trop Med Hyg 59: 265271.
  53. Philippines Statistics Authority, 2015. Philippine Standard Geographic Code. Municipality/City: Cebu City. Available at: http://www.nscb.gov.ph/activestats/psgc/municipality.asp?muncode=072217000&regcode=07&provcode=22. Accessed May 2016.
  54. Cebu City Health Department (CCHD), 2012. Dengue Surveillance Report. Cebu City, Philippines: CCHD.
  55. Cebu City Health Department (CCHD), 2013. Dengue Surveillance Report. Cebu City, Philippines: CCHD.
  56. Catinding NT, Niñal MO, Roque VGJ, , 2008. Manual of Procedures for the Philippines Integrated and Surveillance and Response. Manila, Philippines: Department of Health, 228.
  57. World Health Organization, 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Available at: http://www.who.int/csr/resources/publications/dengue/Denguepublication/en/. Accessed September 2016.
  58. Ona E, , 2012. Revised Dengue Clinical Case Management Guidelines: Administrative Order Number 2012-0006. Manila, Philippines: Department of Health.
  59. Philippines Statistics Authority - National Statistics Office, 2012. Population and Housing Census. Available at: http://www.web0.psa.gov.ph/statistics/census/population-and-housing. Accessed December 11, 2013.
  60. Alera MT, Srikiatkhachorn A, Velasco JM, Tac-An IA, Lago CB, Clapham HE, Fernandez S, Levy JW, Thaisomboonsuk B, Klungthong C, Macareo LR, Nisalak A, Hermann L, Villa D, Yoon I-K, , 2016. Incidence of dengue virus infection in adults and children in a prospective longitudinal cohort in the Philippines. PLoS Negl Trop Dis 10: e0004337.[Crossref]
  61. Yoon I-K, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, Thaisomboonsuk B, Klungthong C, Levy JW, Velasco JM, , 2015. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines. PLoS Negl Trop Dis 9: e0003764.[Crossref]
  62. Lanciotti RS, Calisher CH, Gubler DJ, Chang G-J, Vorndam AV, , 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545551.
  63. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez M-G, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Abdulhak AB, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT-A, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, Leo DD, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, 3rd Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leòn FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, AlMazroa MA, Memish ZA, , 2012. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 21972223.[Crossref]
  64. World Health Organization, 2008. The Global Burden of Disease: 2004 Update. Available at: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/. Accessed April 4, 2016.
  65. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, Naghavi M, Salomon JA, Shibuya K, Vos T, , 2012. GBD 2010: design, definitions, and metrics. Lancet 380: 20632066.[Crossref]
  66. Murray CJL, Barber RM, Foreman KJ, Ozgoren AA, Abd-Allah F, Abera SF, Aboyans V, Abraham JP, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, Achoki T, Ackerman IN, Ademi Z, Adou AK, Adsuar JC, Afshin A, Agardh EE, Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Alla F, Allebeck P, Almazroa MA, Alsharif U, Alvarez E, Alvis-Guzman N, Amare AT, Ameh EA, Amini H, Ammar W, Anderson HR, Anderson BO, Antonio CAT, Anwari P, Arnlöv J, Arsenijevic VSA, Artaman A, Asghar RJ, Assadi R, Atkins LS, Avila MA, Awuah B, Bachman VF, Badawi A, Bahit MC, Balakrishnan K, Banerjee A, Barker-Collo SL, Barquera S, Barregard L, Barrero LH, Basu A, Basu S, Basulaiman MO, Beardsley J, Bedi N, Beghi E, Bekele T, Bell ML, Benjet C, Bennett DA, Bensenor IM, Benzian H, Bernabé E, Bertozzi-Villa A, Beyene TJ, Bhala N, Bhalla A, Bhutta ZA, Bienhoff K, Bikbov B, Biryukov S, Blore JD, Blosser CD, Blyth FM, Bohensky MA, Bolliger IW, Başara BB, Bornstein NM, Bose D, Boufous S, Bourne RRA, Boyers LN, Brainin M, Brayne CE, Brazinova A, Breitborde NJK, Brenner H, Briggs AD, Brooks PM, Brown JC, Brugha TS, Buchbinder R, Buckle GC, Budke CM, Bulchis A, Bulloch AG, Campos-Nonato IR, Carabin H, Carapetis JR, Cárdenas R, Carpenter DO, Caso V, Castañeda-Orjuela CA, Castro RE, Catalá-López F, Cavalleri F, Çavlin A, Chadha VK, Chang JC, Charlson FJ, Chen H, Chen W, Chiang PP, Chimed-Ochir O, Chowdhury R, Christensen H, Christophi CA, Cirillo M, Coates MM, Coffeng LE, Coggeshall MS, Colistro V, Colquhoun SM, Cooke GS, Cooper C, Cooper LT, Coppola LM, Cortinovis M, Criqui MH, Crump JA, Cuevas-Nasu L, Danawi H, Dandona L, Dandona R, Dansereau E, Dargan PI, Davey G, Davis A, Davitoiu DV, Dayama A, De Leo D, Degenhardt L, Del Pozo-Cruz B, Dellavalle RP, Deribe K, Derrett S, Des Jarlais DC, Dessalegn M, Dharmaratne SD, Dherani MK, Diaz-Torné C, Dicker D, Ding EL, Dokova K, Dorsey ER, Driscoll TR, Duan L, Duber HC, Ebel BE, Edmond KM, Elshrek YM, Endres M, Ermakov SP, Erskine HE, Eshrati B, Esteghamati A, Estep K, Faraon EJ, Farzadfar F, Fay DF, Feigin VL, Felson DT, Fereshtehnejad SM, Fernandes JG, Ferrari AJ, Fitzmaurice C, Flaxman AD, Fleming TD, Foigt N, Forouzanfar MH, Fowkes FG, Paleo UF, Franklin RC, Fürst T, Gabbe B, Gaffikin L, Gankpé FG, Geleijnse JM, Gessner BD, Gething P, Gibney KB, Giroud M, Giussani G, Gomez Dantes H, Gona P, González-Medina D, Gosselin RA, Gotay CC, Goto A, Gouda HN, Graetz N, Gugnani HC, Gupta R, Gupta R, Gutiérrez RA, Haagsma J, Hafezi-Nejad N, Hagan H, Halasa YA, Hamadeh RR, Hamavid H, Hammami M, Hancock J, Hankey GJ, Hansen GM, Hao Y, Harb HL, Haro JM, Havmoeller R, Hay SI, Hay RJ, Heredia-Pi IB, Heuton KR, Heydarpour P, Higashi H, Hijar M, Hoek HW, Hoffman HJ, Hosgood HD, Hossain M, Hotez PJ, Hoy DG, Hsairi M, Hu G, Huang C, Huang JJ, Husseini A, Huynh C, Iannarone ML, Iburg KM, Innos K, Inoue M, Islami F, Jacobsen KH, Jarvis DL, Jassal SK, Jee SH, Jeemon P, Jensen PN, Jha V, Jiang G, Jiang Y, Jonas JB, Juel K, Kan H, Karch A, Karema CK, Karimkhani C, Karthikeyan G, Kassebaum NJ, Kaul A, Kawakami N, Kazanjan K, Kemp AH, Kengne AP, Keren A, Khader YS, Khalifa SE, Khan EA, Khan G, Khang YH, Kieling C, Kim D, Kim S, Kim Y, Kinfu Y, Kinge JM, Kivipelto M, Knibbs LD, Knudsen AK, Kokubo Y, Kosen S, Krishnaswami S, Kuate Defo B, Kucuk Bicer B, Kuipers EJ, Kulkarni C, Kulkarni VS, Kumar GA, Kyu HH, Lai T, Lalloo R, Lallukka T, Lam H, Lan Q, Lansingh VC, Larsson A, Lawrynowicz AE, Leasher JL, Leigh J, Leung R, Levitz CE, Li B, Li Y, Li Y, Lim SS, Lind M, Lipshultz SE, Liu S, Liu Y, Lloyd BK, Lofgren KT, Logroscino G, Looker KJ, Lortet-Tieulent J, Lotufo PA, Lozano R, Lucas RM, Lunevicius R, Lyons RA, Ma S, Macintyre MF, Mackay MT, Majdan M, Malekzadeh R, Marcenes W, Margolis DJ, Margono C, Marzan MB, Masci JR, Mashal MT, Matzopoulos R, Mayosi BM, Mazorodze TT, Mcgill NW, Mcgrath JJ, Mckee M, Mclain A, Meaney PA, Medina C, Mehndiratta MM, Mekonnen W, Melaku YA, Meltzer M, Memish ZA, Mensah GA, Meretoja A, Mhimbira FA, Micha R, Miller TR, Mills EJ, Mitchell PB, Mock CN, Mohamed Ibrahim N, Mohammad KA, Mokdad AH, Mola GL, Monasta L, Montañez Hernandez JC, Montico M, Montine TJ, Mooney MD, Moore AR, Moradi-Lakeh M, Moran AE, Mori R, Moschandreas J, Moturi WN, Moyer ML, Mozaffarian D, Msemburi WT, Mueller UO, Mukaigawara M, Mullany EC, Murdoch ME, Murray J, Murthy KS, Naghavi M, Naheed A, Naidoo KS, Naldi L, Nand D, Nangia V, Narayan KM, Nejjari C, Neupane SP, Newton CR, Ng M, Ngalesoni FN, Nguyen G, Nisar MI, Nolte S, Norheim OF, Norman RE, Norrving B, Nyakarahuka L, Oh IH, Ohkubo T, Ohno SL, Olusanya BO, Opio JN, Ortblad K, Ortiz A, Pain AW, Pandian JD, Panelo CI, Papachristou C, Park EK, Park JH, Patten SB, Patton GC, Paul VK, Pavlin BI, Pearce N, Pereira DM, Perez-Padilla R, Perez-Ruiz F, Perico N, Pervaiz A, Pesudovs K, Peterson CB, Petzold M, Phillips MR, Phillips BK, Phillips DE, Piel FB, Plass D, Poenaru D, Polinder S, Pope D, Popova S, Poulton RG, Pourmalek F, Prabhakaran D, Prasad NM, Pullan RL, Qato DM, Quistberg DA, Rafay A, Rahimi K, Rahman SU, Raju M, Rana SM, Razavi H, Reddy KS, Refaat A, Remuzzi G, Resnikoff S, Ribeiro AL, Richardson L, Richardus JH, Roberts DA, Rojas-Rueda D, Ronfani L, Roth GA, Rothenbacher D, Rothstein DH, Rowley JT, Roy N, Ruhago GM, Saeedi MY, Saha S, Sahraian MA, Sampson UK, Sanabria JR, Sandar L, Santos IS, Satpathy M, Sawhney M, Scarborough P, Schneider IJ, Schöttker B, Schumacher AE, Schwebel DC, Scott JG, Seedat S, Sepanlou SG, Serina PT, Servan-Mori EE, Shackelford KA, Shaheen A, Shahraz S, Shamah Levy T, Shangguan S, She J, Sheikhbahaei S, Shi P, Shibuya K, Shinohara Y, Shiri R, Shishani K, Shiue I, Shrime MG, Sigfusdottir ID, Silberberg DH, Simard EP, Sindi S, Singh A, Singh JA, Singh L, Skirbekk V, Slepak EL, Sliwa K, Soneji S, Søreide K, Soshnikov S, Sposato LA, Sreeramareddy CT, Stanaway JD, Stathopoulou V, Stein DJ, Stein MB, Steiner C, Steiner TJ, Stevens A, Stewart A, Stovner LJ, Stroumpoulis K, Sunguya BF, Swaminathan S, Swaroop M, Sykes BL, Tabb KM, Takahashi K, Tandon N, Tanne D, Tanner M, Tavakkoli M, Taylor HR, Te Ao BJ, Tediosi F, Temesgen AM, Templin T, Ten Have M, Tenkorang EY, Terkawi AS, Thomson B, Thorne-Lyman AL, Thrift AG, Thurston GD, Tillmann T, Tonelli M, Topouzis F, Toyoshima H, Traebert J, Tran BX, Trillini M, Truelsen T, Tsilimbaris M, Tuzcu EM, Uchendu US, Ukwaja KN, Undurraga EA, Uzun SB, Van Brakel WH, Van De Vijver S, van Gool CH, Van Os J, Vasankari TJ, Venketasubramanian N, Violante FS, Vlassov VV, Vollset SE, Wagner GR, Wagner J, Waller SG, Wan X, Wang H, Wang J, Wang L, Warouw TS, Weichenthal S, Weiderpass E, Weintraub RG, Wenzhi W, Werdecker A, Westerman R, Whiteford HA, Wilkinson JD, Williams TN, Wolfe CD, Wolock TM, Woolf AD, Wulf S, Wurtz B, Xu G, Yan LL, Yano Y, Ye P, Yentür GK, Yip P, Yonemoto N, Yoon SJ, Younis MZ, Yu C, Zaki ME, Zhao Y, Zheng Y, Zonies D, Zou X, Salomon JA, Lopez AD, Vos T, , 2015. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet 386: 21452191.[Crossref]
  67. World Health Organization, 2016. Disability Weights, Discounting and Age Weighting of DALYs. Available at: http://www.who.int/healthinfo/global_burden_disease/daly_disability_weight/en/. Accessed September 26, 2016.
  68. Undurraga EA, Betancourt-Cravioto M, Ramos-Castañeda J, Martínez-Vega R, Méndez-Galván J, Gubler DJ, Guzmán MG, Halstead SB, Harris E, Kuri-Morales P, Tapia-Conyer R, Shepard DS, , 2015. Economic and disease burden of dengue in Mexico. PLoS Negl Trop Dis 9: e3547.[Crossref]
  69. Luz PM, Grinsztejn B, Galvani AP, , 2009. Disability adjusted life years lost to dengue in Brazil. Trop Med Int Health 14: 237246.[Crossref]
  70. Borja MP, Lorenzo FME, Tallo VL, Rivera PT, Tan AG, , 2007. Final Report of the Burden of Dengue in the Philippines. Manila, Philippines: Department of Health Central Office.
  71. Nealon J, Taurel A-F, Capeding MR, Tran NH, Hadinegoro SR, Chotpitayasunondh T, Chong CK, Wartel TA, Beucher S, Frago C, , 2016. Symptomatic dengue disease in five southeast Asian countries: epidemiological evidence from a dengue vaccine trial. PLoS Negl Trop Dis 10: e0004918.[Crossref]
  72. Capeding RZ, Brion JD, Caponpon MM, Gibbons RV, Jarman RG, Yoon I-K, Libraty DH, , 2010. The incidence, characteristics, and presentation of dengue virus infections during infancy. Am J Trop Med Hyg 82: 330336.[Crossref]
  73. Capeding MR, Chua MN, Hadinegoro SR, Hussain IIHM, Nallusamy R, Pitisuttithum P, Rusmil K, Thisyakorn U, Thomas SJ, Huu Tran N, Wirawan DN, Yoon I-K, Bouckenooghe A, Hutagalung Y, Laot T, Wartel TA, , 2013. Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children. PLoS Negl Trop Dis 7: e2331.[Crossref]
  74. Philippines AFRIMS Virology Research Unit (PAVRU), 2015. PAVRU Research Laboratory. Available at: http://pavru.afrims.org/. Accessed October 29, 2016.
  75. Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, , 2015. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis 9: e0003709.[Crossref]
  76. Fürst T, Keiser J, Utzinger J, , 2012. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 12: 210221.[Crossref]
  77. Peabody JW, Shimkhada R, Tan C, Luck J, , 2005. The burden of disease, economic costs and clinical consequences of tuberculosis in the Philippines. Health Policy Plan 20: 347353.[Crossref]
  78. Tiga DC, Undurraga EA, Ramos-Castañeda J, Martínez-Vega R, Tschampl CA, Shepard D, , 2016. Persistent symptoms of dengue: estimates of the incremental disease and economic burden in Mexico. Am J Trop Med Hyg 94: 10851089.[Crossref]
  79. Wilder-Smith A, , 2014. Dengue vaccines: dawning at last? Lancet 384: 13271329.[Crossref]
  80. Capeding MR, Tran NH, Hadinegoro SRS, Ismail HIHJM, Chotpitayasunondh T, Chua MN, Luong CQ, Rusmil K, Wirawan DN, Nallusamy R, Pitisuttithum P, Thisyakorn U, Yoon I-K, van der Vliet D, Langevin E, Laot T, Hutagalung Y, Frago C, Boaz M, Wartel TA, Tornieporth NG, Saville M, Bouckenooghe A, , 2014. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384: 13581365.[Crossref]
  81. Villar L, Dayan GH, Arredondo-García JL, Rivera DM, Cunha R, Deseda C, Reynales H, Costa MS, Morales-Ramírez JO, Carrasquilla G, Rey LC, Dietze R, Luz K, Rivas E, Montoya MCM, Supelano MC, Zambrano B, Langevin E, Boaz M, Tornieporth N, Saville M, Noriega F, , 2015. Efficacy of a tetravalent dengue vaccine in children in Latin America. N Engl J Med 372: 113123.[Crossref]
  82. Barrett AD, , 2012. Short-course oral corticosteroid therapy is not effective in early dengue infection. Clin Infect Dis 55: 12251226.[Crossref]
  83. Halstead SB, , 2013. Dengue vascular permeability syndrome: what, no T cells? Clin Infect Dis 56: 900901.[Crossref]
  84. Dow G, Mora E, , 2012. The maximum potential market for dengue drugs V 1.0. Antiviral Res 96: 203212.[Crossref]
  85. Erlanger TE, Keiser J, Utzinger J, , 2008. Effect of dengue vector control interventions on entomological parameters in developing countries: a systematic review and meta-analysis. Med Vet Entomol 22: 203221.[Crossref]
  86. Luz PM, Vanni T, Medlock J, Paltiel AD, Galvani AP, , 2011. Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet 377: 16731680.[Crossref]
  87. Hoffmann AA, Montgomery BL, Popovici J, Iturbe-Ormaetxe I, Johnson PH, Muzzi F, Greenfield M, Durkan M, Leong YS, Dong Y, Cook H, Axford J, Callahan AG, Kenny N, Omodei C, McGraw EA, Ryan PA, Ritchie SA, Turelli M, O'Neill SL, , 2011. Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission. Nature 476: 454457.[Crossref]
  88. Atkinson MP, Su Z, Alphey N, Alphey LS, Coleman PG, Wein LM, , 2007. Analyzing the control of mosquito-borne diseases by a dominant lethal genetic system. Proc Natl Acad Sci USA 104: 95409545.[Crossref]
  89. HDT/Sunnex, 2016. Three Regions Selected to Get Free Dengue Vaccines. Manila, Philippines: Sun Star.

Data & Media loading...

  • Received : 07 Jul 2016
  • Accepted : 29 Nov 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error